Article

What We’re Reading: Value-Based Care Partnership; HHS Official Takes Leave of Absence; Vaccine Rollout Plan Unveiled

Author(s):

CareFirst BlueCross BlueShield, MedStar Health announce partnership; HHS official takes medical leave; Trump administration releases vaccine rollout plan.

Value-Based Care Partnership Aims to Improve Affordability, Quality

CareFirst BlueCross BlueShield and MedStar Health announced the organizations will work together to offer value-based health care with the aim of improving affordability, accessibility, quality, and patient experience in the communities they serve. CareFirst is the mid-Atlantic’s largest not-for-profit health care insurance company while MedStar is the region’s largest not-for-profit health care provider. By focusing on preventive care, the organizations estimate improved health outcomes and quality of care will impact the projected costs of care by $400 million over the next 7 years.

HHS Public Affairs Official to Take Medical Leave

HHS Assistant Secretary for Public Affairs Michael Caputo will take a 60-day medical leave of absence to focus on his health and family’s well-being, according to a statement from the department. The announcement comes after Caputo baselessly claimed government scientists are withholding effective coronavirus disease 2019 (COVID-19) treatments to hurt President Donald Trump, CBS reported. Caputo’s senior policy advisor, Paul Alexander, PhD, who was hired to assist with the administration’s COVID-19 response, will also be leaving the department. This week, House Democrats opened an investigation into whether Caputo and his team retroactively altered the CDC's COVID-19 morbidity and mortality reports.

Trump Administration Releases Vaccine Distribution Plan

The Trump administration released its most detailed COVID-19 distribution and administration plan, aimed at making the vaccine free for all Americans, Politico reports. The plan, devised by HHS and the Department of Defense, states rollout of a safe and effective vaccine will begin in January 2021. It also dictates 6.6 million kits of supplies needed to administer vaccines, like syringes and alcohol pads, will be distributed once a vaccine is authorized. CDC is also mandating states and jurisdictions must submit plans on how they would administer a vaccine by October 16, 2020. A final decision on who will be the first to receive vaccines has not been made.

Related Videos
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
1 KOL is featured in this series.
Komal Jhaveri, MD, FACP.
Hans Lee, MD
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
1 expert in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo